Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.68M Buy
10,168
+483
+5% +$165K 0.14% 135
2026
Q1
$3.41M Buy
9,685
+2,032
+27% +$724K 0.16% 114
2025
Q4
$2.5M Sell
7,653
-89
-1% -$28.2K 0.12% 156
2025
Q3
$2.18M Sell
7,742
-28
-0.4% -$8.12K 0.11% 164
2025
Q2
$2.17M Buy
7,770
+125
+2% +$35.4K 0.13% 154
2025
Q1
$2.38M Sell
7,645
-323
-4% -$95.4K 0.15% 126
2024
Q4
$2.08M Sell
7,968
-324
-4% -$96.1K 0.13% 150
2024
Q3
$2.67M Buy
8,292
+1,473
+22% +$482K 0.17% 107
2024
Q2
$2.13M Buy
6,819
+322
+5% +$94.6K 0.15% 137
2024
Q1
$1.85M Buy
6,497
+4,481
+222% +$1.31M 0.11% 210
2023
Q4
$581K Sell
2,016
-12
-0.6% -$3.27K 0.11% 213
2023
Q3
$545K Buy
2,028
+171
+9% +$42.7K 0.1% 213
2023
Q2
$412K Sell
1,857
-1
-0.1% -$232 0.07% 292
2023
Q1
$449K Buy
+1,858
New +$456K 0.09% 257

Other funds holding AMGN

PFG Investments's AMGN Position: Q2 2026 in Review

PFG Investments increased its Amgen (AMGN) stake by 5% in Q2 2026, buying an estimated $165K and bringing the position to 10,168 shares worth $3.68M. The position accounts for 0.14% of the portfolio, ranked #135.

PFG Investments first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 1,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PFG Investments held 10,168 shares of Amgen worth $3.68M as of Q2 2026.
  • PFG Investments bought 483 Amgen shares in Q2 2026, an estimated $165K.
  • Amgen made up 0.14% of PFG Investments's portfolio in Q2 2026, its #135 holding.
  • PFG Investments first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.